Nifty
:
15746.45
Sensex
:
52578.76
-78.00 (-0.49%)
-316.65 (-0.60%)
Nifty
Sensex
:
:
15746.45
52578.76
-78.00 (-0.49%)
-316.65 (-0.60%)

Laurus Labs Ltd.

Pharmaceuticals & Drugs - API

Rating :
72/99

BSE: 540222 | NSE: LAURUSLABS

NSE BSE
632.05
27-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  654.45
  •  660.80
  •  624.00
  •  651.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3466194
  •  22090.00
  •  697.80
  •  144.51

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 33,924.00
  • 34.49
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 35,328.74
  • 0.32%
  • 13.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.30%
  • 8.68%
  • 34.19%
  • FII
  • DII
  • Others
  • 21.5%
  • 3.78%
  • 4.55%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.60
  • 20.37
  • 28.06

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.69
  • 30.63
  • 34.22

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 46.10
  • 38.74
  • 118.91

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 30.93
  • 31.73

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 4.60
  • 4.84

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 14.79
  • 14.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
1,411.93
839.14
68.26%
1,288.42
729.59
76.60%
1,138.84
712.42
59.86%
974.32
550.57
76.97%
Expenses
939.74
647.37
45.16%
862.12
581.42
48.28%
764.97
574.61
33.13%
696.00
467.31
48.94%
EBITDA
472.19
191.77
146.23%
426.30
148.17
187.71%
373.87
137.81
171.29%
278.32
83.26
234.28%
EBIDTM
33.44%
22.85%
33.09%
20.31%
32.83%
19.34%
28.57%
15.12%
Other Income
4.52
1.68
169.05%
6.93
1.92
260.94%
5.12
1.36
276.47%
7.09
4.50
57.56%
Interest
21.91
20.66
6.05%
17.43
20.83
-16.32%
13.68
25.57
-46.50%
15.14
22.53
-32.80%
Depreciation
53.63
46.05
16.46%
51.64
47.55
8.60%
51.00
47.83
6.63%
48.80
45.84
6.46%
PBT
401.17
126.74
216.53%
364.16
81.71
345.67%
314.31
65.77
377.89%
221.47
19.39
1,042.19%
Tax
104.25
16.59
528.39%
91.31
8.24
1,008.13%
72.04
9.22
681.34%
49.69
4.29
1,058.28%
PAT
296.92
110.15
169.56%
272.85
73.47
271.38%
242.27
56.55
328.42%
171.78
15.10
1,037.62%
PATM
21.03%
13.13%
21.18%
10.07%
21.27%
7.94%
17.63%
2.74%
EPS
5.53
0.41
1,248.78%
5.08
1.37
270.80%
4.52
1.06
326.42%
3.21
0.28
1,046.43%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
-
4,813.51
2,831.72
2,291.92
2,056.17
1,904.65
1,777.58
1,326.59
1,159.72
Net Sales Growth
-
69.99%
23.55%
11.47%
7.96%
7.15%
34.00%
14.39%
 
Cost Of Goods Sold
-
2,107.62
1,382.88
1,224.80
1,056.02
989.29
1,000.15
821.27
720.43
Gross Profit
-
2,705.89
1,448.84
1,067.12
1,000.15
915.36
777.43
505.32
439.29
GP Margin
-
56.21%
51.16%
46.56%
48.64%
48.06%
43.74%
38.09%
37.88%
Total Expenditure
-
3,262.83
2,267.17
1,935.93
1,642.85
1,497.01
1,415.38
1,131.46
956.09
Power & Fuel Cost
-
157.75
136.77
109.37
94.21
66.27
57.95
49.86
35.03
% Of Sales
-
3.28%
4.83%
4.77%
4.58%
3.48%
3.26%
3.76%
3.02%
Employee Cost
-
397.04
320.77
276.33
238.14
204.73
175.46
131.38
103.25
% Of Sales
-
8.25%
11.33%
12.06%
11.58%
10.75%
9.87%
9.90%
8.90%
Manufacturing Exp.
-
364.78
239.50
178.96
150.78
139.47
106.97
80.61
47.96
% Of Sales
-
7.58%
8.46%
7.81%
7.33%
7.32%
6.02%
6.08%
4.14%
General & Admin Exp.
-
133.28
114.23
97.48
73.17
65.42
49.09
28.39
27.30
% Of Sales
-
2.77%
4.03%
4.25%
3.56%
3.43%
2.76%
2.14%
2.35%
Selling & Distn. Exp.
-
91.65
61.53
31.96
24.09
22.65
16.49
12.46
12.54
% Of Sales
-
1.90%
2.17%
1.39%
1.17%
1.19%
0.93%
0.94%
1.08%
Miscellaneous Exp.
-
10.71
11.49
17.03
6.44
9.18
9.27
7.49
9.58
% Of Sales
-
0.22%
0.41%
0.74%
0.31%
0.48%
0.52%
0.56%
0.83%
EBITDA
-
1,550.68
564.55
355.99
413.32
407.64
362.20
195.13
203.63
EBITDA Margin
-
32.22%
19.94%
15.53%
20.10%
21.40%
20.38%
14.71%
17.56%
Other Income
-
23.66
5.92
16.15
29.19
33.44
4.36
34.07
8.82
Interest
-
68.16
89.59
88.19
79.64
99.90
111.11
101.11
58.71
Depreciation
-
205.07
187.27
164.19
125.45
105.98
86.41
61.53
32.88
PBT
-
1,301.11
293.61
119.75
237.42
235.19
169.04
66.57
120.86
Tax
-
317.29
38.34
25.99
69.81
43.86
34.90
-1.55
23.64
Tax Rate
-
24.39%
13.06%
21.70%
29.40%
18.65%
20.65%
-2.33%
19.56%
PAT
-
983.58
255.27
93.76
167.61
191.33
134.14
68.12
97.22
PAT before Minority Interest
-
983.82
255.27
93.76
167.61
191.33
134.14
68.12
97.22
Minority Interest
-
-0.24
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
20.43%
9.01%
4.09%
8.15%
10.05%
7.55%
5.13%
8.38%
PAT Growth
-
285.31%
172.26%
-44.06%
-12.40%
42.63%
96.92%
-29.93%
 
EPS
-
18.33
4.76
1.75
3.12
3.57
2.50
1.27
1.81

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
2,597.55
1,769.77
1,558.41
1,482.64
1,330.45
856.80
722.10
358.42
Share Capital
107.32
106.91
106.44
106.03
105.76
82.38
82.13
77.84
Total Reserves
2,485.31
1,658.23
1,446.60
1,370.75
1,218.84
771.47
637.03
277.22
Non-Current Liabilities
692.84
214.24
295.49
174.30
132.34
428.11
363.73
203.92
Secured Loans
429.16
165.02
258.71
141.66
124.56
353.61
303.68
188.17
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
106.13
0.00
0.00
Long Term Provisions
63.19
45.85
30.05
20.84
14.59
6.77
5.13
3.93
Current Liabilities
2,457.15
1,692.38
1,423.90
1,306.89
1,120.75
883.75
802.49
710.87
Trade Payables
1,178.69
615.63
488.31
312.33
263.10
247.61
230.81
227.47
Other Current Liabilities
367.25
261.47
244.50
231.26
199.11
141.05
133.34
164.25
Short Term Borrowings
886.12
790.51
684.21
758.52
644.17
481.42
431.63
312.18
Short Term Provisions
25.09
24.77
6.89
4.78
14.37
13.66
6.70
6.97
Total Liabilities
5,750.69
3,676.39
3,277.80
2,963.83
2,583.54
2,168.66
1,888.32
1,273.21
Net Block
2,170.62
1,726.34
1,629.07
1,480.80
1,229.93
1,021.03
801.01
499.27
Gross Block
3,027.97
2,387.71
2,105.42
1,793.75
1,418.58
1,106.33
986.17
623.32
Accumulated Depreciation
857.35
661.37
476.35
312.95
188.65
85.30
185.16
124.04
Non Current Assets
2,675.83
1,864.33
1,814.84
1,716.23
1,443.71
1,165.92
1,024.41
696.70
Capital Work in Progress
362.17
67.18
109.63
163.18
143.26
69.60
109.67
116.10
Non Current Investment
3.41
3.41
3.40
3.40
3.40
7.04
7.45
0.00
Long Term Loans & Adv.
108.52
40.80
25.58
29.36
25.95
29.22
93.94
68.50
Other Non Current Assets
31.11
26.60
47.16
39.50
41.17
39.03
12.34
12.82
Current Assets
3,074.86
1,812.06
1,462.96
1,247.59
1,139.82
1,002.73
862.27
574.81
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,575.45
905.22
681.94
584.78
509.05
487.09
475.50
328.10
Sundry Debtors
1,306.06
791.42
709.94
570.59
567.61
444.86
285.07
194.88
Cash & Bank
48.46
1.74
3.02
3.06
4.09
28.77
58.88
23.20
Other Current Assets
144.89
51.77
32.84
30.53
59.08
42.00
42.82
28.64
Short Term Loans & Adv.
88.39
61.91
35.22
58.63
25.01
23.86
22.75
19.80
Net Current Assets
617.71
119.68
39.05
-59.30
19.07
118.98
59.78
-136.06
Total Assets
5,750.69
3,676.39
3,277.80
2,963.82
2,583.53
2,168.65
1,888.32
1,273.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
733.00
347.42
297.66
342.49
331.99
181.97
-64.71
121.23
PBT
1,301.11
293.61
119.75
237.42
235.19
169.04
66.57
120.86
Adjustment
254.45
293.21
247.69
216.47
199.38
200.57
136.26
83.06
Changes in Working Capital
-594.06
-199.76
-44.46
-49.48
-52.45
-154.37
-250.72
-59.27
Cash after chg. in Working capital
961.50
387.06
322.99
404.41
382.12
215.23
-47.89
144.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-228.50
-39.64
-25.32
-61.91
-50.13
-33.26
-16.82
-23.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-940.99
-221.13
-252.88
-384.15
-288.67
-312.20
-396.95
-311.82
Net Fixed Assets
-572.84
-236.25
-254.84
-394.43
-354.15
-76.75
-353.86
Net Investments
-260.57
-0.01
-6.57
-1.22
-24.40
-7.01
-18.65
Others
-107.58
15.13
8.53
11.50
89.88
-228.44
-24.44
Cash from Financing Activity
254.70
-127.66
-44.77
42.24
-53.61
103.32
486.08
203.03
Net Cash Inflow / Outflow
46.71
-1.37
0.02
0.59
-10.30
-26.91
24.42
12.44
Opening Cash & Equivalents
1.69
2.97
3.00
2.42
12.81
39.53
15.11
2.67
Closing Cash & Equivalent
48.46
1.69
2.97
3.00
2.42
12.81
39.53
15.11

Financial Ratios

Standalone /

Consolidated
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
48.32
33.02
29.18
27.86
25.05
99.86
83.92
37.83
ROA
20.87%
7.34%
3.00%
6.04%
8.05%
6.61%
4.31%
7.64%
ROE
45.15%
15.39%
6.19%
11.97%
18.12%
18.65%
14.47%
33.42%
ROCE
39.82%
14.14%
8.22%
13.68%
16.52%
16.35%
13.74%
19.96%
Fixed Asset Turnover
1.78
1.26
1.18
1.29
1.53
1.73
1.66
1.87
Receivable days
79.52
96.76
101.97
100.40
95.66
73.56
65.47
61.02
Inventory Days
94.05
102.29
100.87
96.48
94.12
97.00
109.61
102.73
Payable days
93.08
80.47
72.80
61.13
59.14
58.52
69.29
86.77
Cash Conversion Cycle
80.50
118.58
130.03
135.75
130.64
112.05
105.79
76.98
Total Debt/Equity
0.56
0.60
0.67
0.66
0.64
1.20
1.14
1.54
Interest Cover
20.09
4.28
2.36
3.98
3.35
2.52
1.66
3.06

Annual Reports:

FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Laurus Labs gets license to manufacture, market 2-Deoxy-D-Glucose in India
    2nd Jul 2021, 14:18 PM

    2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country

    Read More
  • Laurus Labs reports around 3-fold jump in Q4 consolidated net profit
    30th Apr 2021, 10:37 AM

    The company has reported a standalone net profit of Rs 292.78 crore for the quarter ended March 31, 2021

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.